Aphtalit

Aphtalit is a topical pharmaceutical product developed by Ingalfarma specifically for the treatment of canker sores (aphthous ulcers) and minor oral ulcers. It is designed to alleviate pain and accelerate the healing process of small lesions within the oral cavity. As a specialty pharma product in Ingalfarma's oral health portfolio, it is positioned alongside other treatments like Dentoxol. While the specific active ingredients and molecular mechanism of action are not publicly detailed in the company's high-level pipeline, such treatments typically function by forming a protective barrier over the ulcerated tissue and/or providing local anti-inflammatory or analgesic effects to facilitate recovery.

Brand names

Aphtalit